AU2003209542A8 - Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders - Google Patents

Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders

Info

Publication number
AU2003209542A8
AU2003209542A8 AU2003209542A AU2003209542A AU2003209542A8 AU 2003209542 A8 AU2003209542 A8 AU 2003209542A8 AU 2003209542 A AU2003209542 A AU 2003209542A AU 2003209542 A AU2003209542 A AU 2003209542A AU 2003209542 A8 AU2003209542 A8 AU 2003209542A8
Authority
AU
Australia
Prior art keywords
crysteine
medicament
substituted
manufacture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003209542A
Other versions
AU2003209542A1 (en
Inventor
Carlo Ghisalberti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003209542A8 publication Critical patent/AU2003209542A8/en
Publication of AU2003209542A1 publication Critical patent/AU2003209542A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003209542A 2002-03-11 2003-03-10 Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders Abandoned AU2003209542A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2002A000510 2002-03-11
IT2002MI000510A ITMI20020510A1 (en) 2002-03-11 2002-03-11 TOPICAL COMPOSITIONS CONTAINING L-CISTEIN DERIVATIVES
PCT/IB2003/000857 WO2003075901A2 (en) 2002-03-11 2003-03-10 Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders

Publications (2)

Publication Number Publication Date
AU2003209542A8 true AU2003209542A8 (en) 2003-09-22
AU2003209542A1 AU2003209542A1 (en) 2003-09-22

Family

ID=11449487

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003209542A Abandoned AU2003209542A1 (en) 2002-03-11 2003-03-10 Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders

Country Status (3)

Country Link
AU (1) AU2003209542A1 (en)
IT (1) ITMI20020510A1 (en)
WO (1) WO2003075901A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351745B2 (en) * 2004-12-22 2008-04-01 Avon Products, Inc Compositions and methods of their use for improving the condition and appearance of skin
CN101467991B (en) * 2007-08-02 2012-02-01 复旦大学 Uses of allyl cysteine and analogue thereof in preparing medicament for treating myocardial damage
JP6596733B2 (en) * 2015-07-14 2019-10-30 学校法人日本大学 COMPOUND, PROTEIN MODIFICATION REAGENT CONTAINING THE COMPOUND, AND METHOD FOR LABELING PROTEIN
US20180362456A1 (en) * 2015-12-07 2018-12-20 Ems S/A New compounds with antioxidant and antiaging activity
JP7356707B2 (en) * 2018-11-15 2023-10-05 国立大学法人神戸大学 Method for producing amino acid-N-carboxylic acid anhydride
CN115501125A (en) * 2022-10-20 2022-12-23 澳门科技大学 H for repairing skin lesions 2 S donor gel and H 2 Preparation method of S donor gel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE733993A (en) * 1968-06-14 1969-12-03
US3671643A (en) * 1969-09-15 1972-06-20 Oreal Treatment of excessive sebaceous glands secretion with substituted cysteamine compounds
BE788945A (en) * 1971-09-20 1973-03-19 Oreal
FR2155776B1 (en) * 1971-10-04 1974-11-15 Rech Pharmaceut Scient
FR2187326B1 (en) * 1972-06-15 1975-10-17 Rech Pharm Scientifiques
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations

Also Published As

Publication number Publication date
WO2003075901A2 (en) 2003-09-18
ITMI20020510A1 (en) 2003-09-11
AU2003209542A1 (en) 2003-09-22
WO2003075901A3 (en) 2003-12-31
ITMI20020510A0 (en) 2002-03-11

Similar Documents

Publication Publication Date Title
HUS1400011I1 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
AU2003270903A8 (en) A video game for assisting healing of the human body
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
AU2003286567A8 (en) Methods for the treatment of skin disorders
IL166150A0 (en) Apparatus for altering the body temperature of a patient
HK1081173A1 (en) Phenethanolamine derivative for the treatment of respiratory diseases
AU2003300791A1 (en) Combination therapy for the treatment of pain
IL173145A (en) Use of a pak inhibitor for the production of a medicament for the treatment of a joint disease
PL375964A1 (en) Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis
EP1536834A4 (en) Design of chemokine analogs for the treatment of human diseases
HK1085920A1 (en) Use of dihydroimidazolones for the manufacture of a medicament for the treatment of epilepsy in dogs
HK1075843A1 (en) 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms, pain, and incontinence
PL1670482T5 (en) Use of ciclesonide for the treatment of respiratory diseases
AU2002338303A1 (en) Therapeutic compositions for the treatment of a respiratory tract disease
ZA200405853B (en) Use of adapalene for the treatment of dermatological disorders
AU2003209542A8 (en) Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
AU2003303217A8 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
IL162509A (en) Use of deoxypeganine for the production of a drug for treating clinical depression
HRP20041160A2 (en) Novel combination for the treatment of airway disorders
AU2003301758A8 (en) Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
GB0201025D0 (en) The treatment of degenerative diseases
IL162492A (en) Use of alkylphosphocholines for producing a medicament for the preventative treatment of protozoan diseases
AU2003214317A1 (en) Use of a novel class of drugs for the treatment of parasitic diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase